Supplemental Fig. 1 : Ataxin-3 protein cleavage occurs to a greater extent when expression is directed to the brain compared to the eye. Western immunoblot, probed with anti-MJD polyclonal antibody. 7d heads from w control, or flies expressing the Myc-Atx3Q78 protein in all neurons of the eye and brain with elav-gal4 or only in the eye with gmr-gal4. There was more cleavage fragment with expression in neurons compared to the eye, which has neurons but also is predominantly pigment and other accessory cells. Both drivers are expressed from the same stage of development. Previous studies also indicate that the full-length protein is more selectively toxic to neurons compared to pigment cells of the eye (S1). Genotypes: w 1118 . elav-gal4/UAS-Myc-Atx3Q78. gmr-gal4/UAS-Myc-Atx3Q78. 
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Supplemental Fig 3. Proteasome and calpain inhibitors do not significantly modify
Ataxin-3 protein cleavage in SL2 cells. Ataxin-3 protein cleavage was carried out following the protocol detailed in Fig2A. The constructs used were pUAST-Myc-Atx3Q84 driven by heat shock (pHS-gal4). Cleavage products of a ~ 50 kDa (**) and ~37 kDa (****) were observed as in Fig 2B. As in previous experiments, zVAD-fmk reduced the level of ~37 kDa fragment (****), and a slight build up of higher molecular weight products including~50 kDa fragment (**) relative to the full length protein (*) was observed. zFA-fmk treatment had no effect. MG132 (a proteasome inhibitor) did not significantly alter the amount of ~37 kDa fragment in SL2 cells. However, the relative intensity of minor bands (***) between ~ 50 kDa and ~37 kDa fragments consistently appeared weaker, suggesting the involvement of the proteasome for the appearance of certain Ataxin-3 fragments in SL2 cells. ALLN (a caspase inhibitor) did not alter the cleavage pattern significantly. Combined treatment of zVAD and MG132 did not elicit a synergistic effect, suggesting they are independent processes. Fig. 3A for schematic with the location of putative caspase sites. Cleavage of the 6M mutant protein was dramatically reduced relative that of the WT protein, while the 3M protein showed an intermediate effect. To the right, a longer exposure of the western immunoblot with the 6M sample is shown to highlight the difference in the amount of ~37 kDa fragment (**) relative to full length protein (<). A non-specific band is indicated (*). B. Detection of the N-terminal tag with an anti-Myc antibody did not detect the ~37 kDa product from the fly brain. This antibody was used to compare and match protein expression levels of the full length Ataxin-3 protein (<). C. Effect of caspase site mutations on the cleavage of the double tagged Myc-Atx3Q84-Flag protein. The 6M protein showed a nearly complete suppression of cleavage. To the right is a longer exposure of the 6M part of the western blot to highlight the lack of cleavage of the 6M protein. <, Full length protein; **, ~37 kDa fragment; *, non-specific band.
